Implante de TAVI transapical y revascularización miocárdica mínimamente invasiva
Lourdes Montero, Enrique Villagrán, Rosa Beltrao and 3 more
Cirugía Cardiovascular · 2021
doi:10.1016/j.circv.2021.01.006 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Resumen: La enfermedad coronaria en candidatos a implante de prótesis aórtica transcatéter es frecuente. El abordaje híbrido que combina el implante de una prótesis transcatéter por vía transapical y la revascularización miocárdica quirúrgica mínimamente invasiva es una opción segura y eficaz en pacientes con enfermedad vascular periférica o estenosis en la arteria coronaria descendente anterior no apta para intervención percutánea. Reportamos nuestra experiencia en 2 casos. Abstract: Coronary artery disease in transcatheter aortic valve implantation candidates is prevalent. Hybrid approach combining transapical valve implantation and minimally invasive direct coronary artery bypass is a safe and effective option in patients with peripheral vascular disease and/or stenosis in left anterior coronary artery not suitable for percutaneous intervention. We report our experience in 2 cases.
Abstract licence: CC BY-NC-ND
References8
8 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.